Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 593 Glioblastoma 573 Glioma 298 Central Nervous System Neoplasms 208 Gliosarcoma 177 Neuroblastoma 175 Astrocytoma 174 Oligodendroglioma 112 Carcinoma, Non-Small-Cell Lung 92 Medulloblastoma 80 Breast Neoplasms 74 Ependymoma 61 Sarcoma 60 Meningioma 60 Neoplasm Metastasis 57 Recurrence 56 Melanoma 56 Neoplasms 51 Lung Neoplasms 48 Neurofibromatosis 1 43 Meningeal Carcinomatosis 40 Osteosarcoma 39 Pheochromocytoma 38 Rhabdomyosarcoma 37 Wilms Tumor 36 Paraganglioma 35 Lymphoma, Non-Hodgkin 32 Neuroectodermal Tumors, Primitive, Peripheral 29 Lymphoma 27 Sarcoma, Ewing 26

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Tetanus × CNS × Clear all

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡